국내 소아 지역획득폐렴의 치료

키워드

참고문헌 (36)

1. Walker CL, "Global burden of childhood pneumonia and diarrhoea", Lancet, 381, pp.1405~1416 (2013)
2. Rudan I, "Epidemiology and etiology of childhood pneumonia", Bull World Health Organ, 86, pp.408~416 (2008)
3. McCabe C, "Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules", Arch Intern Med, 169, pp.1525~1531 (2009)
4. Bradley JS, "The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America", Clin Infect Dis, 53, pp.e25~e76 (2011)
5. Chang Hyu Lee, "A nationwide study of children and adolescents with pneumonia who visited Emergency Department in South Korea in 2012", Korean Journal of Pediatrics, 59(3), pp.132~138 (2016), 대한소아과학회
6. 이윤희, "소아 대·소엽성 폐렴의 임상 양상 및 원인에 대한 고찰", Allergy Asthma & Respiratory Diseases, 19(3), pp.271~281 (2009), 대한 소아알레르기 호흡기학회
7. 박경미, "소아 환자에서의 괴사성 폐렴의 임상적 고찰", Allergy Asthma & Respiratory Diseases, 2(3), pp.208~212 (2014), 대한 소아알레르기 호흡기학회
8. 정희영, "다중 역전사 중합연쇄반응으로 증명된 급성 바이러스성 하기도 감염 양상", Allergy Asthma & Respiratory Diseases, 17(4), pp.344~353 (2007), 대한 소아알레르기 호흡기학회
9. 문정희, "2개 지역에서 소아의 급성 바이러스성 하기도염의 유행성에 관한 역학조사", Pediatric Infection and Vaccine, 9(2), pp.193~200 (2002), 대한소아감염학회
10. 김혜영, "2010-2011년 부산 경남 지역에서 급성 하기도 감염으로 입원한 소아의 호흡기 바이러스 임상 양상", Allergy Asthma & Respiratory Diseases, 22(3), pp.265~272 (2012), 대한 소아알레르기 호흡기학회
11. 권정현, "2002-2006년 서울지역 입원 환자에서의 급성 바이러스성하기도염의 역학조사", Allergy Asthma & Respiratory Diseases, 18(1), pp.26~36 (2008), 대한 소아알레르기 호흡기학회
12. 김은경, "Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years", Korean Journal of Pediatrics, 58(5), pp.172~177 (2015), 대한소아과학회
13. 안연화, "최근 4년간 영유아 Mycoplasma pneumoniae 폐렴의 임상양상에 대한 고찰", Allergy Asthma & Respiratory Diseases, 17(3), pp.249~259 (2007), 대한 소아알레르기 호흡기학회
14. 양은애, "소아 대엽성 폐렴에서 마이코플라즈마 폐렴의 임상적 특성", Allergy Asthma & Respiratory Diseases, 22(3), pp.256~264 (2012), 대한 소아알레르기 호흡기학회
15. Hong KB, "Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011", Emerg Infect Dis, 19, pp.1281~1284 (2013)
16. Lee KY, "Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children", Pediatr Pulmonol, 41, pp.263~268 (2006)
17. Yang J, "Cytokines in Mycoplasma pneumoniae infections", Cytokine Growth Factor Rev, 15, pp.157~168 (2004)
18. 유선영, "Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children", Allergy, Asthma & Immunology Research, 6(1), pp.22~26 (2014), 대한천식알레르기학회
19. 윤유숙, "Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study", Infection and Chemotherapy, 46(4), pp.239~247 (2014), 대한감염학회[DOI]
20. Advani S, "Detecting respiratory viruses in asymptomatic children", Pediatr Infect Dis J, 31, pp.1221~1226 (2012)
21. Song JH, "Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study", Clin Infect Dis, 28, pp.1206~1211 (1999)
22. Baquero F, "Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview", Microb Drug Resist, 1, pp.115~120 (1995)
23. Kim SH, "Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study", Antimicrob Agents Chemother, 56, pp.1418~1426 (2012)
24. Newman RE, "Impact of a guideline on management of children hospitalized with community-acquired pneumonia", Pediatrics, 129, pp.e597~e604 (2012)
25. Williams DJ, "Antibiotic choice for children hospitalized with pneumonia and adherence to national guidelines", Pediatrics, 136, pp.44~52 (2015)
26. Song JH, "High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)", Antimicrob Agents Chemother, 48, pp.2101~2107 (2004)
27. Hendaus MA, "Virus-induced secondary bacterial infection: a concise review", Ther Clin Risk Manag, 11, pp.1265~1271 (2015)
28. Beadling C, "How do viral infections predispose patients to bacterial infections?", Curr Opin Infect Dis, 17, pp.185~191 (2004)
29. Morens DM, "Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness", J Infect Dis, 198, pp.962~970 (2008)
30. Deng JC, "Viral-bacterial interactions-therapeutic implications", Influenza Other Respir Viruses, 7(Suppl 3), pp.24~35 (2013)
31. Lucero MG, "Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age", Cochrane Database Syst Rev, (4), pp.CD004977~ (2009)
32. de St Maurice A, "Racial and regional differences in rates of invasive pneumococcal disease", Pediatrics, 136, pp.e1186~e1194 (2015)
33. Kronman MP, "Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007", Pediatrics, 127, pp.411~418 (2011)
34. Shaughnessy EE, "Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era", Curr Opin Pediatr, 28, pp.786~793 (2016)
35. Griffin MR, "U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination", N Engl J Med, 369, pp.155~163 (2013)
36. Madhi SA, "A role for Streptococcus pneumoniae in virus-associated pneumonia", Nat Med, 10, pp.811~813 (2004)

관련 논문AI추천